Brookstone Capital Management Exact Sciences Corp Transaction History
Brookstone Capital Management
- $5.98 Billion
- Q4 2024
A detailed history of Brookstone Capital Management transactions in Exact Sciences Corp stock. As of the latest transaction made, Brookstone Capital Management holds 9,876 shares of EXAS stock, worth $544,463. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,876
Previous 14,953
33.95%
Holding current value
$544,463
Previous $1.02 Million
45.58%
% of portfolio
0.01%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding EXAS
# of Institutions
670Shares Held
162MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$979 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$873 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$790 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$665 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$368 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.76B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...